Insider Stock Trading History of Davenport Fred B Jr


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Davenport Fred B Jr since year 2005. The trader's CIK number is 1181154. At the time of this reporting, Davenport Fred B Jr is the President of Pharmaceutical Product Development Inc . (stock ticker symbol PPDI). See this page for all insider trading activities at Pharmaceutical Product Development Inc .


Stock purchases, sales, and option exercises reported by insider Davenport Fred B Jr since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2006-11-02 PPDI Pharmaceutical Product Development Inc Option Ex 95,833 18.24 1,748,473
2006-11-02 PPDI Pharmaceutical Product Development Inc Sale 18,300 30.18 552,257
2006-11-02 PPDI Pharmaceutical Product Development Inc Sale 71,233 29.83 2,125,165
2006-11-02 PPDI Pharmaceutical Product Development Inc Sale 8,200 29.61 242,802
2006-05-22 PPDI Pharmaceutical Product Development Inc Sale 80,000 36.49 2,918,960
2006-05-22 PPDI Pharmaceutical Product Development Inc Option Ex 80,000 14.95 1,196,000
2006-05-22 PPDI Pharmaceutical Product Development Inc Sale 80,000 36.49 2,918,960
2006-05-22 PPDI Pharmaceutical Product Development Inc Option Ex 80,000 14.95 1,196,000
2006-02-15 PPDI Pharmaceutical Product Development Inc Option Ex 30,000 28.16 844,800
2006-02-15 PPDI Pharmaceutical Product Development Inc Sale 30,000 66.12 1,983,750
2006-02-14 PPDI Pharmaceutical Product Development Inc Option Ex 17,500 26.22 458,850
2006-02-14 PPDI Pharmaceutical Product Development Inc Sale 17,500 66.83 1,169,525

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davenport Fred B Jr (President of Pharmaceutical Product Development Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.